New longer-term data reinforce safety of Roche ’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorder

Basel, 22 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new pooled pivotal satralizumab safety results for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating central nervous system disorder. These data are being presented at the 6th Annual Meeting of the European Academy of Neurology (EAN) and show satralizumab was well-tolerated in a broad patient population – including adolescents, for whom there is no approved medicine. Satralizumab is an investigational humanised monoclonal antibody that targets the interleukin-6 (IL-6) receptor, believed to play a key role in the inflammation that occurs in people with NMOSD. Satralizumab was designed using novel antibody recycling technology, allowing for longer duration of antibody circulation and subcutaneous dosing every four weeks.“The open-label extension data from the Phase III studies reinforce the safety, observed tolerability and potential of satralizumab as a future treatment option for this chronic condition,” said Professor Jerome de Seze, Department Head of Neurology and Clinical Investigation Centre at the Unive rsity of Strasbourg, France. “Although significant strides have been made recently in understanding NMOSD, more approved treatment options offering a well-tolerated safety profile with a less frequent, subcutaneous dosing are needed for this underserved population.” Pooled data from the double-blind periods of the SAkuraStar and SAkuraSky...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news

Related Links:

Publication date: Available online 30 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): R.D. Russell, L.J. Black, N.M. Pham, A. Begley
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: August 2020Source: Multiple Sclerosis and Related Disorders, Volume 43Author(s): Amgad Droby, Lazar Fleysher, Maria Petracca, Kornelius Podranski, Junqian Xu, Michelle Fabian, Malgorzata MarjaĊ„ska, Matilde Inglese
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 30 May 2020Source: Brain, Behavior, and ImmunityAuthor(s): Chalystha Yie Qin Lee, Ashley E. Franks, Elisa L. Hill-Yardin
Source: Brain, Behavior, and Immunity - Category: Neurology Source Type: research
Publication date: Available online 30 May 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
Publication date: Available online 30 May 2020Source: American Journal of Infection ControlAuthor(s): Hiroki Kitagawa, Minako Mori, Toshinori Hara, Seiya Kashiyama, Norifumi Shigemoto, Hiroki Ohge
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
Publication date: Available online 30 May 2020Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyAuthor(s): Kevin C. Lee, Sung-Kiang Chuang
Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology - Category: ENT & OMF Source Type: research
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Hema S. Gopalan, Anoop Misra
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Sachin Atre, Sona Deshmukh, Manjusha Kulkarni
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 30 May 2020Source: Pharmacological ResearchAuthor(s): Ling Wang, Ke Deng, Liang Gong, Liang Zhou, Sapna Sayed, Huan Li, Qi Sun, Zijie Su, Zhongyuan Wang, Shanshan Liu, Huifang Zhu, Jiaxing Song, Desheng Lu
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 31 May 2020Source: Pharmacology &TherapeuticsAuthor(s): Jie Yu, Bingling Zhong, Qingwen Xiao, Lida Du, Ying Hou, Hong-Shuo Sun, Jin-Jian Lu, Xiuping Chen
Source: Pharmacology and Therapeutics - Category: Drugs & Pharmacology Source Type: research
More News: Academies | Allergy & Immunology | Alzheimer's | Anaphylactic Shock | Autism | Autoimmune Disease | Biology | Biotechnology | Blindness | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Child Development | Corticosteroid Therapy | Diabetes | Disability | Endocrinology | France Health | Hospitals | Infectious Diseases | International Medicine & Public Health | Japan Health | Men | Multiple Sclerosis | Neurology | Neuroscience | Opthalmology | Pharmaceuticals | Politics | Respiratory Medicine | Science | Spinal Muscular Atrophy | Study | Switzerland Health | Urinary Tract Infections | USA Health | WHO | Women